|
|
Volumn 34, Issue 32, 2016, Pages 3914-3920
|
|
PANCREOX: A randomized phase III study of fluorouracil/leucovorin with or without oxaliplatin for second-line advanced pancreatic cancer in patients who have received gemcitabine-based chemotherapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CAPECITABINE;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IRINOTECAN;
OXALIPLATIN;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
DEOXYCYTIDINE;
PLATINUM COMPLEX;
ADULT;
ADVANCED CANCER;
AGED;
ANEMIA;
ARTICLE;
BLOOD TOXICITY;
BOLUS INJECTION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER SURVIVAL;
CHOLANGITIS;
CONTINUOUS INFUSION;
CONTROLLED STUDY;
DEHYDRATION;
DIARRHEA;
DRUG DOSE REDUCTION;
DRUG SAFETY;
DRUG WITHDRAWAL;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
FOLLOW UP;
HUMAN;
HYPOKALEMIA;
LUNG EMBOLISM;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
MULTICENTER STUDY;
MUSCLE WEAKNESS;
NEUTROPENIA;
OPEN STUDY;
OVERALL SURVIVAL;
PANCREAS CANCER;
PERIPHERAL NEUROPATHY;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
QUALITY OF LIFE;
QUALITY OF LIFE ASSESSMENT;
RANDOMIZED CONTROLLED TRIAL;
RETREATMENT;
THROMBOCYTOPENIA;
VOMITING;
ANALOGS AND DERIVATIVES;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
PANCREAS TUMOR;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DEOXYCYTIDINE;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
ORGANOPLATINUM COMPOUNDS;
PANCREATIC NEOPLASMS;
QUALITY OF LIFE;
|
|
EID: 84995527140
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2016.68.5776 Document Type: Article |
|
Times cited : (222)
|
|
References (11)
|
